Synonym:
4-
CAS Number 142715-48-8
Empirical Formula (Hill Notation) C31H36N4O6 · HCl
Molecular Weight 597.10
MDL number MFCD00911858
| Related Categories | Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Drug Efflux Pumps, Modulators for MDR/TAP Transporters, |
| assay | >98% (HPLC) |
| form | powder |
| color | white to off-white |
| solubility | DMSO: >5 mg/mL |
| storage temp. | 2-8°C |
Sold for research purposes under agreement from Pfizer Inc.
CP-100356 is a specific inhibitor of MDR1 (P-Gp), the protypical ABC transporter. The compound has low uM to nM potency for inhibiting several MDR-1 substrates (calcein-AM, digoxin) in transfected MDCKII cells. CP-100356 also inhibits prazosin transport in human breast cancer resistance protein (BCRP)-transfected MDCKII cells, suggesting that it acts as a dual inhibitor. CP-100356 does not inhibit multidrug resistance-associated protein 2 (MPR2 IC50 >15 mM).
Customers Also Viewed
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?